发明名称 Progesterone treatment of cancer
摘要 Natural progesterone inhibits the proliferation of normal breast epithelial cells in vivo, as well as breast cancer cells in vitro. The anti-proliferative activity of natural progesterone in normal tissue is due to its ability to induce apoptosis. The genes P53 and bcl-2 genetically control the apoptic process and are involved in the natural progesterone induced apoptosis. Natural progesterone levels similar to levels seen during the third trimester of pregnancy exhibited a strong anti-proliferative effect on at least two breast cancer cell lines. Apoptosis was induced in the stronger progesterone receptor expressing T47-D cells. Exposure of T47-D breast cancer cells to natural progesterone significantly down regulated expression of bcl-2 and concomitantly up-regulated expression of p53, indicating both genes are involved in natural progestorone-induced apoptosis. A composition containing exogenous natural progesterone formulated for topical application is disclosed which may be used to establish and maintain a plasma concentration of natural progesterone of greater than 10 nanograms per ml which level is sufficient to destroy breast cancer cells.
申请公布号 AU4406899(A) 申请公布日期 1999.12.06
申请号 AU19990044068 申请日期 1999.05.18
申请人 TERESA S. WILEY;BENT FORMBY 发明人 TERESA S. WILEY;BENT FORMBY
分类号 A61K31/56 主分类号 A61K31/56
代理机构 代理人
主权项
地址